MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Depression and cognitive impairment in isolated focal-onset dystonia: prevalence and risk factors in a group of Romanian patients

    OL. Bajenaru, I. Popescu-Olaru, E. Serban, L. Cozma, F. Raicu, R. Cocos, L. Dumitrescu, BO. Popescu (Bucharest, Romania)

    Objective: To assess the prevalence of depression and cognitive impairment and their potential risk factors in a group of Romanian patients with isolated focal-onset dystonia…
  • 2019 International Congress

    Efficacy and Safety of AbobotulinumtoxinA in Adults with Cervical Dystonia: Similar Results Between 1mL and 2mL Dilution Methods

    K. Dashtipour, R. Hauser, S. Isaacson, D. Truong, L. Bahroo, A. Patel, P. Maisonobe, J. Otto (Loma Linda, CA, USA)

    Objective: To evaluate efficacy and safety of a single injection of abobotulinumtoxinA using 1-mL or 2-mL dilution in adults with CD. Background: AbobotulinumtoxinA is approved…
  • 2019 International Congress

    RDP is associated with bulbar and limb weakness: broadening the phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP)

    I. Haq, B. Snively, J. Cook, C. Suerken, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

    Objective: To describe a new finding of weakness associated with RDP. Background: RDP is caused by mutations of the ATP1A3 gene. The phenotype of RDP…
  • 2019 International Congress

    Genotype-phenotype relations for the isolated Dystonia Genes TOR1A, THAP1, GNAL, ANO3, KMT2B, PRKRA and HPCA: MDSGene Systematic Review

    LM. Lange, J. Junker, S. Loens, L. Olschewski, S. Schaake, S. Petkovic, M. Kasten, A. Westenberger, A. Domingo, A. Madoev, I. König, C. Marras, KP. Bhatia, S. Camargos, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review genotypes and phenotypes of monogenic isolated dystonia. Background: The Movement Disorder Society Genetic mutation database (MDSGene at www.mdsgene.org) provides an overview…
  • 2019 International Congress

    Neuromuscular electrical stimulation for the treatment of jaw-closing dystonia

    C. Miller-Patterson, E. Burton (Pittsburgh, PA, USA)

    Objective: To measure whether neuromuscular electrical stimulation (NMES) increases jaw-opening distance and improves quality-of-life in jaw-closing dystonia patients. Background: An index case with progressive supranuclear…
  • 2019 International Congress

    A protocol to probe the mechanisms underlying disordered sub-cortical processing in cervical dystonia using emotional faces.

    S. Purcell, J. Monahan, I. Ndukwe, O. Killian, S. Narasimham, M. Perez Denia, O. Duggan, S. O Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: Probing the mechanisms underlying disordered sub-cortical processing in the pathogenesis of the non-motor symptoms of cervical dystonia (CD) is of great clinical importance. We…
  • 2019 International Congress

    Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes

    E. Timmers, M. Smit, A. Kuiper, A. Bartels, S. Vander Veen, A. Vander Stouwe, P. Santens, B. Bergmans, M. Tijssen (Groningen, Netherlands)

    Objective: Systematically study NMS in M-D in direct comparison to other types of dystonia and healthy controls. Background: Myoclonus-dystonia (M-D) due to a SGCE mutation…
  • 2019 International Congress

    OnabotulinumtoxinA treatment in adults with spasticity reduces caregiver burden: Results from the ASPIRE study

    A. Esquenazi, A. Ellenbogen, G. Wittenberg, K. Ngo, J. Largent, A. Zuzek, G. Francisco, W. Jost (Elkins Park, PA, USA)

    Objective: To examine the impact of onabotulinumtoxinA treatment in adult patients with spasticity on caregiver burden over 2 years from the Adult Spasticity International Registry…
  • 2019 International Congress

    Tic Detector – Role of Electromyography

    W. Deeb, S. Cernera, A. Gunduz, M. Okun (Gainesville, FL, USA)

    Objective: To use surface electromyography (EMG) to detect and characterize motor tics. Background: Tourette syndrome is a complex neuropsychiatric disorder characterized by a combination of…
  • 2019 International Congress

    Adult-onset neuronal intranuclear inclusion disease presenting with intractable resting and intention tremor

    YY. Chang, MY. Lan, YF. Chen, JS. Liu (Kaohsiung, Taiwan)

    Objective: To report a rare case of neuronal intranuclear inclusion disease (NIID) presenting with intractable resting and intention tremor. Background: The NIID is a slowly…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley